Stay updated with breaking news from Dealers license. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Creso Pharma’s acquisition target Halucenex secures deal with Nucro Technics to test psilocybin liquid formulations It will also provide CPH with the ability to develop and validate methods for potency, component identification and microbiology for botanical psilocybe mushrooms grown in the future at Halucenex. Nucro-Technics employs more than 170 scientific support personnel at its state-of-the-art 60,000 square foot facility in Toronto. Creso Pharma Ltd s (ASX:CPH) (FRA:1X8) target acquisition Halucenex Life Sciences Inc has signed an agreement with leading pharmaceutical contract research organisation Nucro-Technics to provide microbiology and chemistry test work for a salient delivery solution using synthetic psilocybin, which will be used in upcoming clinical trial submissions. ....
Creso Pharma’s strong quarter marks evolution into a broader-based pharmaceutical company: chairman The surge in revenue along with business ties-ups across major global markets following regulatory changes and the acquisition of an established psychedelics company could transform it into a broader-based pharma company. CERES Natural Remedies flagship store in Vermont, US Creso Pharma Ltd (ASX:CPH) (OTCMKTS:COPHF) (FRA:1X8) has witnessed a strong first quarter, with total revenue rising by 237% from the preceding quarter, marking the company’s evolution into a broader-based pharmaceutical company, according to non-executive chairman Adam Blumenthal. The surge in the group’s revenue growth during the quarter highlighted the growing demand for the company’s products, as regulatory shifts across cannabis industries globally continue to unlock growth opportunities. ....
Creso Pharma Ltd welcomes strong progress made by target acquisition Halucenex Life Sciences Inc proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Baystreet.ca - Mycology Interest on the Rise as Researchers Unearth More Benefits of Functional Mushroom Products baystreet.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baystreet.ca Daily Mail and Mail on Sunday newspapers.
In other industry news of note: Mydecine Innovations Group (CSE:MYCO) (MYCO.CNQ), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for mainstream use, recently announced that it has partnered with ProPharma Group, the leading provider of regulatory and compliance services to the pharmaceutical, biotech, and medical device industries. As part of the agreement, ProPharma Group will provide regulatory advisement as the company seeks approval from the Food and Drug Administration (FDA) for its drug development platform as well as the Company s various stage clinical trials. ProPharma Group is a globally recognized firm with a strong track record of working with life sciences and biopharma companies to ensure full compliance with all FDA regulations, including all necessary steps for eventual global federal approvals, said Josh Bartch, CEO and Co-Founder of Mydecine. Myd ....